<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Toll-like receptors (TLRs) and the scavenger receptor CD36 are key molecular sensors for the innate immune response to invading pathogens </plain></SENT>
<SENT sid="1" pm="."><plain>However, these receptors may also recognize endogenous "danger signals" generated during brain injury, such as <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and trigger a maladaptive inflammatory reaction </plain></SENT>
<SENT sid="2" pm="."><plain>Indeed, CD36 and TLR2 and 4 are involved in the <z:mp ids='MP_0001845'>inflammation</z:mp> and related tissue damage caused by <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Because CD36 may act as a coreceptor for TLR2 heterodimers (TLR2/1 or TLR2/6), we tested whether such interaction plays a role in ischemic brain injury </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The TLR activators FSL-1 (TLR2/6), Pam3 (TLR2/1), or <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (TLR4) were injected intracerebroventricularly into <z:mp ids='MP_0002169'>wild-type</z:mp> or CD36-null mice, and inflammatory gene expression was assessed in the brain </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of TLR activators on the <z:mpath ids='MPATH_124'>infarct</z:mpath> produced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was also studied </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The <z:mp ids='MP_0001845'>inflammatory response</z:mp> induced by TLR2/1 activation, but not TLR2/6 or TLR4 activation, was suppressed in CD36-null mice </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, TLR2/1 activation failed to increase <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in CD36-null mice, whereas TLR2/6 or TLR4 activation exacerbated postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> and increased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, the systemic <z:mp ids='MP_0001845'>inflammatory response</z:mp> evoked by TLR2/6 activation, but not by TLR2/1 activation, was suppressed in CD36-null mice </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In the brain, TLR2/1 signaling requires CD36 </plain></SENT>
<SENT sid="10" pm="."><plain>The cooperative signaling of TLR2/1 and CD36 is a critical factor in the <z:mp ids='MP_0001845'>inflammatory response</z:mp> and tissue damage evoked by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, suppression of CD36-TLR2/1 signaling could be a valuable approach to minimize postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> and the attendant brain injury </plain></SENT>
</text></document>